Antibacterial activity and therapeutic efficacy of Fl-PRPRPL-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection
dc.contributor.author | Thangamani, Shankar | en |
dc.contributor.author | Nepal, Manish | en |
dc.contributor.author | Chmielewski, Jean | en |
dc.contributor.author | Seleem, Mohamed N. | en |
dc.date.accessioned | 2020-09-21T16:10:06Z | en |
dc.date.available | 2020-09-21T16:10:06Z | en |
dc.date.issued | 2015-01-01 | en |
dc.date.updated | 2020-09-21T16:10:02Z | en |
dc.description.abstract | The antibacterial activities and therapeutic efficacy of the cationic, unnatural proline-rich peptide Fl-PRPRPL-5 were evaluated against multidrug-resistant Staphylococcus aureus in a mouse model of skin infection. Fl-PRPRPL-5 showed potent activity against all clinical isolates of S. aureus tested, including methicillin- and vancomycin-resistant S. aureus (MRSA and VRSA, respectively). Fl-PRPRPL-5 was also superior in clearing established in vitro biofilms of S. aureus and Staphylococcus epidermidis, compared with the established antimicrobials mupirocin and vancomycin. Additionally, topical treatment of an MRSA-infected wound with Fl-PRPRPL-5 enhanced wound closure and significantly reduced bacterial load. Finally, 0.5% Fl-PRPRPL-5 significantly reduced the levels of the inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) in wounds induced by MRSA skin infection. In conclusion, the results of this study suggest the potential application of Fl-PRPRPL-5 in the treatment of staphylococcal skin infections. | en |
dc.description.version | Published version | en |
dc.format.extent | Pages 5749-5754 | en |
dc.format.extent | 6 page(s) | en |
dc.format.medium | Electronic-eCollection | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.2147/DDDT.S94505 | en |
dc.identifier.eissn | 1177-8881 | en |
dc.identifier.issn | 1177-8881 | en |
dc.identifier.orcid | Seleem, Mohamed [0000-0003-0939-0458] | en |
dc.identifier.other | dddt-9-5749 (PII) | en |
dc.identifier.pmid | 26543355 (pubmed) | en |
dc.identifier.uri | http://hdl.handle.net/10919/100018 | en |
dc.identifier.volume | 9 | en |
dc.language.iso | en | en |
dc.publisher | Dove Medical Press | en |
dc.rights | Creative Commons Attribution-NonCommercial 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | en |
dc.subject | Chemistry, Medicinal | en |
dc.subject | Pharmacology & Pharmacy | en |
dc.subject | antimicrobial peptides | en |
dc.subject | Staphylococcus aureus | en |
dc.subject | biofilms | en |
dc.subject | anti-inflammatory | en |
dc.subject | skin infection | en |
dc.subject | AUREUS | en |
dc.subject | PEPTIDES | en |
dc.subject | COMPLICATIONS | en |
dc.subject | INFLAMMATION | en |
dc.subject | BACTERIA | en |
dc.subject | BIOFILM | en |
dc.subject | ALPHA | en |
dc.subject | RISK | en |
dc.subject | 1115 Pharmacology and Pharmaceutical Sciences | en |
dc.subject.mesh | Skin | en |
dc.subject.mesh | Animals | en |
dc.subject.mesh | Biofilms | en |
dc.subject.mesh | Staphylococcus epidermidis | en |
dc.subject.mesh | Staphylococcal Skin Infections | en |
dc.subject.mesh | Disease Models, Animal | en |
dc.subject.mesh | Fluoresceins | en |
dc.subject.mesh | Peptides | en |
dc.subject.mesh | Tumor Necrosis Factor-alpha | en |
dc.subject.mesh | Oligopeptides | en |
dc.subject.mesh | Inflammation Mediators | en |
dc.subject.mesh | Interleukin-6 | en |
dc.subject.mesh | Anti-Bacterial Agents | en |
dc.subject.mesh | Interleukin-1beta | en |
dc.subject.mesh | Methicillin-Resistant Staphylococcus aureus | en |
dc.title | Antibacterial activity and therapeutic efficacy of Fl-PRPRPL-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection | en |
dc.title.serial | Drug Design Development and Therapy | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Article | en |
dc.type.other | Journal | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/Biomedical Sciences and Pathobiology | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/CVM T&R Faculty | en |
pubs.organisational-group | /Virginia Tech | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse m.pdf
- Size:
- 740.37 KB
- Format:
- Adobe Portable Document Format